Interestingly, expression of both CD55 and CD59 membrane-bound complement inhibitors was found specifically elevated in intermediate CD14highCD16+ monocytes from COVID-19 patients when compared to HCs (Supplementary Figures 1C, D, respectively). The gene discussed is CD55; the disease is COVID-19.